These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2944852)

  • 1. Functional Kunitz inhibitor binding domain in plasmin-derived light chain as shown by affinity chromatography.
    Chauvet J; Chabbat J; Acher R
    Int J Pept Protein Res; 1986 Jul; 28(1):85-90. PubMed ID: 2944852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation of human Glu-plasminogen, Lys-plasminogen and plasmin by high-performance affinity chromatography on Asahipak GS gel coupled with p-aminobenzamidine.
    Ito N; Noguchi K; Kazama M; Shimura K; Kasai K
    J Chromatogr; 1985 Nov; 348(1):199-204. PubMed ID: 2935552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiostatin formation involves disulfide bond reduction and proteolysis in kringle 5 of plasmin.
    Stathakis P; Lay AJ; Fitzgerald M; Schlieker C; Matthias LJ; Hogg PJ
    J Biol Chem; 1999 Mar; 274(13):8910-6. PubMed ID: 10085135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of the human plasmin domain recognized by the unique plasmin receptor of group A streptococci.
    Broder CC; Lottenberg R; Boyle MD
    Infect Immun; 1989 Sep; 57(9):2597-605. PubMed ID: 2547717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrolysis of plasma kallikrein by trypsin and plasmin and the formation of active fragments.
    Sampaio CA; Vidmar S; Hamaguchi A; Sampaio MU
    Adv Exp Med Biol; 1986; 198 Pt B():105-11. PubMed ID: 2949543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and purification of microplasmin.
    Wu HL; Shi GY; Bender ML
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8292-5. PubMed ID: 2960974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of the bovine basic pancreatic trypsin inhibitor (Kunitz) to human Glu1-, Lys77-, Val442-, and Val561-plasmin: a comparative study.
    Ascenzi P; Amiconi G; Bolognesi M; Menegatti E; Guarneri M
    Biochim Biophys Acta; 1990 Aug; 1040(1):134-6. PubMed ID: 2143086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance affinity chromatography of plasmin and plasminogen on a hydrophilic vinyl-polymer gel coupled with p-aminobenzamidine.
    Shimura K; Kazama M; Kasai K
    J Chromatogr; 1984 Jun; 292(2):369-82. PubMed ID: 6235238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new method of isolation and some properties of the heavy chain of human plasmin.
    Rickli EE; Otavsky WI
    Eur J Biochem; 1975 Nov; 59(2):441-7. PubMed ID: 128454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoaffinity labeling of functionally different lysine-binding sites in human plasminogen and plasmin.
    Ryan TJ; Keegan MC
    Biochim Biophys Acta; 1985 Aug; 830(2):187-94. PubMed ID: 3160389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrodynamic studies on the streptokinase complexes of human plasminogen, Val442-plasminogen, plasmin, and the plasmin-derived light (B) chain.
    Barlow GH; Summaria L; Robbins KC
    Biochemistry; 1984 May; 23(11):2384-7. PubMed ID: 6236844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifications to the lysine Sepharose method of plasminogen purification which ensure plasmin-free Glu-plasminogen.
    Grant AJ
    Biochem Int; 1990; 20(3):519-27. PubMed ID: 2140680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The isolation and characterization of a ternary human plasmin B-chain-streptokinase-plasminogen complex.
    Summaria L; Boreisha I; Barlow GH; Robbins KC
    Thromb Haemost; 1987 Aug; 58(2):772-7. PubMed ID: 2960030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic peptides derived from the sequence around the plasmin cleavage site in vitronectin. Use in mapping the PAI-1 binding site.
    Gechtman Z; Sharma R; Kreizman T; Fridkin M; Shaltiel S
    FEBS Lett; 1993 Jan; 315(3):293-7. PubMed ID: 7678553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of microplasminogen. A low molecular weight form of plasminogen.
    Shi GY; Wu HL
    J Biol Chem; 1988 Nov; 263(32):17071-5. PubMed ID: 2972717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent molecular weight approximately 92 000 hybrid plasminogen activator derived from human plasmin amino-terminal and urokinase carboxyl-terminal domains.
    Robbins KC; Tanaka Y
    Biochemistry; 1986 Jun; 25(12):3603-11. PubMed ID: 2941075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interaction of heavy and light chains of plasmin with fibrinogen E and D fragments].
    Kudinov SA; Lezhen TI
    Biokhimiia; 1984 Dec; 49(12):2003-7. PubMed ID: 6240993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isolation of fibronectin peptide fragments of various sizes and biological activity using affinity chromatography on an immobilized plasmin].
    Chubukina AN; Zlatopol'skiĭ AD; Zaĭdenberg MA; Bychkova VV
    Vopr Med Khim; 1989; 35(6):103-5. PubMed ID: 2534245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for high-molecular weight active peptides originating from porcine plasmin autolysis.
    Grimard M
    Biochimie; 1976; 58(11-12):1409-12. PubMed ID: 138450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.